Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$2.06 - $3.76 $522,242 - $953,220
-253,516 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$1.83 - $5.41 $2 Million - $5.9 Million
-1,090,329 Reduced 81.14%
253,516 $578,000
Q4 2019

Feb 14, 2020

SELL
$4.03 - $6.5 $2.63 Million - $4.25 Million
-653,802 Reduced 32.73%
1,343,845 $7.11 Million
Q3 2019

Nov 14, 2019

SELL
$2.8 - $12.85 $30,239 - $138,780
-10,800 Reduced 0.54%
1,997,647 $8.61 Million
Q2 2019

Aug 14, 2019

SELL
$10.6 - $13.12 $103,880 - $128,575
-9,800 Reduced 0.49%
2,008,447 $23.9 Million
Q1 2019

May 15, 2019

BUY
$9.96 - $13.44 $395,412 - $533,568
39,700 Added 2.01%
2,018,247 $25.1 Million
Q4 2018

Feb 14, 2019

SELL
$8.47 - $14.71 $589,512 - $1.02 Million
-69,600 Reduced 3.4%
1,978,547 $18.7 Million
Q3 2018

Nov 14, 2018

BUY
$13.7 - $17.12 $257,560 - $321,856
18,800 Added 0.93%
2,048,147 $29.5 Million
Q2 2018

Aug 14, 2018

SELL
$14.63 - $19.19 $3.7 Million - $4.85 Million
-252,921 Reduced 11.08%
2,029,347 $32.7 Million
Q1 2018

May 15, 2018

BUY
$16.06 - $25.35 $5.65 Million - $8.91 Million
351,600 Added 18.21%
2,282,268 $0
Q4 2017

Feb 14, 2018

BUY
$10.51 - $17.22 $7.53 Million - $12.3 Million
716,580 Added 59.02%
1,930,668 $32.4 Million
Q3 2017

Nov 14, 2017

BUY
$10.14 - $14.85 $12.3 Million - $18 Million
1,214,088
1,214,088 $17 Million

Others Institutions Holding GLYC

About GLYCOMIMETICS INC


  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $16.3M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.